RIT1 oncoproteins escape LZTR1-mediated proteolysis
Author(s) -
Pau Castel,
Alice Cheng,
Antonio Cuevas-Navarro,
David B. Everman,
Alex G. Papageorge,
Dhirendra K. Simanshu,
Alexandra Tankka,
Jacqueline Galeas,
Anatoly Urisman,
Frank McCormick
Publication year - 2019
Publication title -
science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 12.556
H-Index - 1186
eISSN - 1095-9203
pISSN - 0036-8075
DOI - 10.1126/science.aav1444
Subject(s) - proteolysis , chemistry , biochemistry , enzyme
Defective degradation as disease mechanism Ubiquitination often targets proteins for destruction. Castelet al. describe a mechanism by which mutations in the small guanine triphosphatase RIT1 may act to cause certain developmental disorders and cancers. They detected a protein, LZTR1, that interacted with wild-type RIT1 but not with oncogenic mutant forms of RIT1. LZTR1 acts as a substrate-specific adaptor for a ubiquitin ligase. Altered forms of RIT1 that are not subject to ubiquitin-mediated degradation thus accumulate. Because RIT1 functions in growth factor signaling and excessive signaling, these findings may explain the malignancies associated with RIT1 mutations.Science , this issue p.1226
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom